Roger Rush, Ph.D. has been named vice president of preclinical development, Wolfe Laboratories. Dr. Rush has more than 25 years of international experience in pharmaceutical R&D with a focus on preclinical research, development, and program management, particularly in the transition of discovery research candidates to clinical development.     “We’re delighted to have Dr. Rush as part of our team,” said Janet Wolfe, Ph.D, president of WLI. “His wealth of experience will ...